Loading
Life sciences · Journal article
Bioactive Materials · July 28, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a preclinical proof-of-concept study demonstrating a novel wearable hydrogel dressing combining laser-induced graphene, itraconazole, and real-time sensing for treatment and monitoring of Trichophyton rubrum in murine models. The work shows promise for integrating photothermal therapy, drug delivery, and immunomodulation, but lacks human validation, comparative efficacy data, and safety profiling necessary for clinical translation.
Preclinical in vivo study (murine model). Murine models with Trichophyton rubrum infection. Intervention: LIG+ITZ@PCS hydrogel dressing (laser-induced graphene with itraconazole in polycaprolactone/silk fibroin matrix) with sunlight exposure.
LIG+ surface charge of +43.1 mV enables targeted fungal capture Sunlight exposure induces mild photothermal effect reaching ∼45°C with controlled ITZ release Combined PTT and ITZ achieve T. rubrum eradication and biofilm disruption without recurrence in murine models
No human data; murine model results may not translate to clinical efficacy or safety
This work represents early-stage innovation in smart antimicrobial wound dressings. Clinicians should await human safety, efficacy, and usability studies before considering clinical application; current evidence supports continued basic research and development only.
Preclinical proof-of-concept in murine models demonstrating a novel theranostic hydrogel dressing with synergistic antifungal activity and real-time monitoring capability, but lacking human efficacy or safety data.
As stated by the source record.
Quoted from the source exactly as published.
This work represents early-stage innovation in smart antimicrobial wound dressings. Clinicians should await human safety, efficacy, and usability studies before considering clinical application; current evidence supports continued basic research and development only.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The complexity, high recurrence rate, and need for long-term monitoring in dermatophytosis treatment underscore the demand for high-performance antifungal strategies. Here, we present a theranostic wearable hydrogel dressing (LIG+ITZ@PCS hydrogel) that integrates laser-induced graphene (LIG) with co-encapsulated itraconazole (ITZ) for synergistic therapy and real-time monitoring. This platform features a cationic LIG+ surface (+43.1 mV) for targeted fungal capture. Sunlight exposure induces a mild photothermal effect (∼45°C), which enables the controlled release of ITZ. The combined action of photothermal therapy (PTT) and ITZ inflicts multimodal injury on Trichophyton rubrum (T. rubrum), inducing ferroptosis along with other cellular damage mechanisms. This mechanism achieves T. rubrum eradication and biofilm disruption without recurrence in murine models. The conductive LIG network facilitates real-time, smartphone-based tracking of fungal load through voltage signals. Furthermore, LIG+ITZ@PCS hydrogel exert a powerful modulates immune microenvironment effect. This intelligent system, which integrates low-temperature phototherapy, immunotherapy, and real-time sensing, offers a comprehensive platform for dermatophytosis management.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.